2020 Sustainability Report 2020 Sustainability Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Participant List
Participant list Please find below a list of current participants in theAustralian Life Sciences Remuneration Review. For a complete list by super sector, sector and segment refer to Mercer WIN®. A. Menarini Australia B Braun Avitum Australia Cardinal Health AbbVie Australia Bausch & Lomb (Australia) Cepheid Abbott Australasia Baxter Healthcare Cochlear Acrux Bayer Coloplast Australia Alcon Beckman Coulter - Diagnostics Convatec (Australia) Alere Beckman Coulter - Life Sciences CooperVision Australia Allergan Becton Dickinson DH Dental Alphapharm Besins Healthcare Australia DSM Nutritional Products Amgen Biogen Idec Australia Device Technologies Aust Ascom Australia Biomerieux Australia Ecolab Aspen Australia Blackmores Edwards Lifesciences Astellas Pharma Boehringer Ingelheim Eisai Australia AstraZeneca Boston Scientific International Elanco Australasia Australian Nuclear Science and Technology Boucher & Muir Eli Lilly Australia Organisation (ANSTO) Bristol-Myers Squibb Evolution Health Australian Pharmaceutical Industries CSL Ferring Pharmaceuticals B Braun Australia © September 2020 Mercer Consulting (Australia) Pty Ltd Australian Life Sciences Remuneration Review 4.1 Participant list Fresenius Kabi Australia Integrated DNA Technologies (IDT) Merck Serono Fresenius Medical Care Australia Invisalign Australia Mindray Medical International GE Australia Healthcare Ipsen Molnlycke Health Care GN Netcom Australia J&J Pacific Mundipharma Galderma Australia Janssen-Cilag - Australia Nevro Medical Australia Getinge Johnson & Johnson Medical -
Stallings Book 4 Print.Pdf (3.603Mb)
Black Performance and Cultural Criticism Valerie Lee and E. Patrick Johnson, Series Editors Stallings_final.indb 1 5/17/2007 5:14:41 PM Stallings_final.indb 2 5/17/2007 5:14:41 PM Mutha ’ is half a word Intersections of Folklore, Vernacular, Myth, and Queerness in Black Female Culture L. H. Stallings The Ohio State University Press Columbus Stallings_final.indb 3 5/17/2007 5:14:42 PM Copyright © 2007 by The Ohio State University. All rights reserved. Library of Congress Cataloging-in-Publication Data Horton-Stallings, LaMonda. Mutha’ is half a word : intersections of folklore, vernacular, myth, and queerness in black female culture / L.H. Stallings. p. cm.—(Black performance and cultural criticism) Includes bibliographical references and index. ISBN-13: 978-0-8142-1056-7 (cloth : alk. paper) ISBN-10: 0-8142-1056-2 (cloth : alk. paper) ISBN-13: 978-0-8142-9135-1 (cd-rom) ISBN-10: 0-8142-9135-X (cd-rom) 1. American literature—African American authors—History and criticism. 2. American literature—women authors—History and criticism. 3. African American women in literature. 4. Lesbianism in literature. 5. Gender identity in literature. 6. African American women— Race identity. 7. African American women—Intellectual life. 8. African American women— Folklore. I. Title. II. Series PS153.N5H68 2007 810.9'353—dc22 2006037239 Cover design by Jennifer Shoffey Forsythe. Cover illustration by Michel Isola from shutterstock.com. Text design and typesetting by Jennifer Shoffey Forsythe in Adobe Garamond. Printed by Thomson-Shore, Inc. The paper used in this publication meets the minimum requirements of the American National Standard for Information Sciences—Permanence of Paper for Printed Library Materials. -
DANAHER CORPORATION (Exact Name of Registrant As Specified in Its Charter)
DANAHER CORP /DE/ FORM 10-K (Annual Report) Filed 3/10/2004 For Period Ending 12/31/2003 Address 2099 PENNSYLVANIA AVE N.W., 12TH FLOOR WASHINGTON, District of Columbia 20006 Telephone 202-828-0850 CIK 0000313616 Industry Scientific & Technical Instr. Sector Technology Fiscal Year 12/31 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-8089 DANAHER CORPORATION (Exact name of registrant as specified in its charter) Delaware 59-1995548 (State of incorporation) (I.R.S.Employer Identification number) 2099 Pennsylvania Ave. N.W., 12 th Floor Washington, D.C. 20006 -1813 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: 202-828-0850 Securities Registered Pursuant to Section 12(b) of the Act: Title of each class Name of Exchanges on which registered Common Stock $.01 par Value New York Stock Exchange, Inc. Pacific Stock Exchange, Inc. Securities registered pursuant to Section 12(g) of the Act: NONE (Title of Class) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. -
The Ultimatum XLS This Multi-Chamber, Multi-Driver Confection Looks to the Seated Listener Like Any Other Two-Way Stand-Mount
October 2011 NEAT XLS Loudspeaker A small loudspeaker that is truly mesmerizing and emotionally moving. Review By Malcolm Steward NEAT Acoustics produced its first loudspeaker back in 1989. That unassuming-looking but ground-breaking model, the Petite, quickly became my 'reference' compact, high-end, two-way. It has retained that position for more than two decades. While the latest mark for iteration, the Petite SX, has replaced the somewhat utilitarian looking original, with its almost bitumen-like finished cabinet, little else – certainly nothing fundamental – has changed in all that time... except the price, of course. The Petite has now been joined in my listening room – and affections – by another and rather grander. NEAT: The Ultimatum XLS This multi-chamber, multi-driver confection looks to the seated listener like any other two-way stand-mount. However, closer inspection reveals that the bass-midrange section uses two, isobarically loaded 168mm drivers; the HF uses a single Sonomex domed XL driver; and on the top face of the enclosure sit two EMIT 25mm planar/ribbon super HF units – aka super-tweeters. That enclosure is unusual as well. It is fabricated from slow-growing, Birch plywood, chosen for its consistency and its excellent behavior in terms of resonance. The front baffle consists of controlled density fiberboard bonded to the main cabinet with a Polyethylene membrane. This produces a remarkably inert platform upon which to mount the mid-bass and high frequency drivers. Each of this array of drive units is located in its own discrete chamber: the largest of these cavities is also ported to provide ideal loading for the rear unit of the isobaric bass pairing. -
2019 Annual Report
1984 2019 2019 MARKED DANAHER’S 35TH ANNIVERSARY To honor this milestone, the front cover of this year's annual report features the original Danaher logo and bright blue color palette. We proudly celebrate our company's history as the prelude to a 35 future filled with opportunity. By living our core values of building the best team, continuously improving, “ listening to our customers every day and driving innovation, we ultimately deliver long-term shareholder value.” Thomas P. Joyce, Jr. Financial Operating Highlights (dollars in millions except per share data and number of associates) 2019 2018 Sales $ 17,911.1 $ 17,048.5 Operating Profit $ 3,269.4 $ 3,055.1 Net Earnings $ 2,432.3 $ 2,406.3 Net Earnings Per Share (diluted) $ 3.26 $ 3.39 Operating Cash Flow $ 3,657.4 $ 3,644.0 Investing Cash Flow $ (1,166.1) $ (2,873.9) Financing Cash Flow $ 16,589.9 $ (797.4) Capital Expenditures $ (635.5) $ (583.5) Capital Disposals $ 12.8 $ 6.3 Free Cash Flow (Operating Cash Flow less Capital Expenditures plus Capital Disposals) $ 3,034.7 $ 3,066.8 Number of Associates 60,000 58,000 Total Assets* $ 62,081.6 $ 47,832.5 Total Debt ** $ 21,729.1 $ 9,740.3 Stockholders’ Equity $ 30,281.9 $ 28,226.7 Total Capitalization (Total Debt plus Stockholders’ Equity) $ 52,011.0 $ 37,967.0 * 2018 data includes both continuing and discontinued operations ** Long-Term Debt ($21,516.7 for 2019 and $9,688.5 for 2018) plus Notes Payable and Current Portion of Long-Term Debt ($212.4 for 2019 and $51.8 for 2018) All financial data set forth in this annual report relates solely to continuing operations unless otherwise indicated. -
Copyright © 2014 Hifi
1 Copyright © 2014 Hifi Pig 2 Copyright © 2014 Hifi Pig This Issue Hifi Pig CONTENTS Magazine EDITORIAL January 2014 Issue 2 4 Editorial 11 Readers System www.hifipig.com 16 Dealers System Telephone: +33 (0)2 97 23 70 78 E mail: [email protected] Siret - 488 244 898 00018 REVIEWS t’s been a busy month here at Hifi Pig. Not 22 Coffman Labs G-1A Preamplifier only have we had lots of new kit that has 28 The Cartridge Man Isolator Icome in for review but we’ve also covered masses and masses of news - which you can 33 Simple Audio “GO” Bluetooth Speaker read here . 34 Oriton Audio R33 Support System CES gave us a lot to talk about on the site and as always we aimed to be first to bring this news to 37 Astintrew Powered USB our readers. 41 Atoll Electronique IN200 SE Integrated We’ve also expanded our Facebook and Twitter Amplifier & CD200 SE-2 CD Player feeds and the number of followers we have on our increasingly important social media feeds - 46 LessLoss DFPC Signature Power Cables it’s an ideal opportunity for us to get feedback 51 COMPETITION Win Astintrew’s Powered from our readers in a more informal setting. It USB as reviewed by Danny Worth this month. also lets us know that what we are writing about 52 REVIEW LINKS is what you want to read about. However, as always if you have any comments 54 ALBUM REVIEWS you’d like to make or have any questions then let us know. -
Eprocurement Small Order Process: Vendors with Item Catalogs
eProcurement Small Order Process: Vendors with Item Catalogs Updated April 18, 2012 V000142495 ABCAM INC V000137051 ILLUMINA INC V000081265 ACO MEDICAL SUPPLY V000014509 INTERMOUNTAIN SCIENTIFIC V000125369 ACTIVE MOTIF V000080847 INTREX COMPUTERS INC V000112094 AFFYMETRIX INC V000006118 INVITROGEN CORPORATION V000114793 AGILENT TECHNOLOGIES INC V000130596 INVIVOGEN V000000082 ALLTECH ASSOCIATES INC V000005714 JACKSON IMMUNORES V000000118 AMRESCO V000001442 JACKSON LAB V000152997 ANASPEC INC V000001558 LABORATORY SAFETY V000132756 ASYLUM RESEARCH CORP V000047258 LABREPCO INC V000000126 ATCC V000108167 LEICA MICROSYSTEMS V000068824 ATLANTA BIOLOGICALS V000088788 LI-COR INC V000162435 ATLANTIC FITNESS V000111733 LIST BIOLOGICAL LABS V000000307 BASI V000002832 LONZA WALKERSVILLE INC V000000261 BD BIOSCIENCES V000149811 MATRIX TECH V000000259 BECKMAN COULTER V000135360 MEDICAL SPECIALTIES V000176191 BENCHMARK TECH V000022962 MIDWEST SCIENTIFIC V000101618 BETHYL LABS V000078901 MILTENYI BIOTEC INC V000159330 BIO BASIC V000008542 MOLECULAR DEVICES INC V000004901 BIOGENIX LABORATORIES V000001340 MP BIOMEDICALS V000145647 BIOLEGEND V000188293 NETA SCIENTIFIC INC V000157241 BIOLINE USA INC V000186184 NEWEAST BIOSCIENCES V000112934 BIOLOGICAL SPECIALTY CORP V000001880 NEW ENGLAND BIOLABS INC V000000303 BIO-RAD V000004850 NEWPORT V000000305 BIO-TEK INSTRUMENTS V000052248 NIKON INSTRUMENTS INC V000000349 BRAINTREE V000167597 OCEAN OPTICS V000190375 BUTLER SCHEIN V000001937 OLYMPUS AMERICA INC V000000429 CAMCOR V000139707 OPEN BIOSYSTEMS V000000454 -
The Secret Mountain Laboratory and Even Saw the Reign of Terror That the Poor Designers and Technicians Were Living Under
the d\b\e \"ere seCret by Don Lancaster Don Lancaster's INCREDIBLE SECRET MONEY MACHINE II Synergetlcs Press Box 809 • Thatcher AZ • 85552 (928) 428-4073 Copyright © 1978, 1992, 2010 by Don Lancaster. Published by Synergetics Press 3860 West First Street, Box 809, Thatcher, AZ,85552. (928) 428-4073. THIRD EDITION FIRST PRINTING-2010 Al l rights reserved. Reproduction or use, without express permission, of editorial or pictorial content, in any manner, is strictly prohibited. No liability is assumed for damages resulting from the use of the information contained herein. The only warranty, express or implied, is "approximate quantity one." International Standard Book Number ISBN 978-1-882193-12-7 Printed in a tinaja near Thatcher, Arizona, USA. INTRODUCI10N TO THE SECOND EDITION Fourteen Years Later... History always repeats Itself. First as a tragedy and then as a farce. Somehow it Is has become the fall of 1992. This Incredible Secret Money Machine is now fourteen years old. And is selling better than ever. But the last remaining mountain of them has just vanished out of my storeroom. So a revision would seem to be in order. Probably the greatest indicator of your ongoing enthUSiasm Is how long you can keep your copy of an ISMM before it gets permanently ripped off. The average time seems to be fifteen weeks. A half life, sort of. Or maybe a time between reincarnations. I guess I am not into revisionism, so I won't. With a few obvious adaptions, most of this book is as accurate and as useful now as It was then. -
2017 INVESTOR & ANALYST DAY December 14, 2017
2017 INVESTOR & ANALYST DAY December 14, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, deterioration of or instability in the economy, the markets we serve and the financial markets, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify, consummate and integrate appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to integrate the recent acquisitions of Pall Corporation and Cepheid and achieve the anticipated benefits of such transactions, contingent -
2010 Annual Report
2010 ANNUAL REPORT Segmentation Voice of the Customer Dynamic Resource Allocation Brand Management Policy Deployment MEASURING Risk Management Value Selling Innovation Talent SUCCESS Accelerated Product Development Sales Force Initiatives Emerging Markets Digital Marketing DBS 2010 ANNUAL REPORT In 2010, Danaher updated reporting segments to reflect the evolution of our business to a science and technology company. We now report results in five business segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental; and Industrial Technologies. TEST & MEASUREMENT Our Test & Measurement segment is a leading, global provider of electronic measurement instruments and monitoring, management and optimization tools for communications and enterprise networks and related services. Our products are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and communications networks and services. Customers for our products and services include manufacturers of electronic instruments; service, installation and maintenance professionals; network equipment manufacturers who design, develop, manufacture and install network equipment and service providers who implement, maintain and manage communications networks and services. Also included in our Test & Measurement segment are our mobile tool and wheel service businesses. Financial Operating Highlights 2010 2009 (dollars in thousands except per share data and number of associates) Sales $ 13,202,602 $ 11,184,938 Operating profit -
Case No COMP/M.6175 - DANAHER/ BECKMAN COULTER
EN Case No COMP/M.6175 - DANAHER/ BECKMAN COULTER Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 16/06/2011 In electronic form on the EUR-Lex website under document number 32011M6175 Office for Publications of the European Union L-2985 Luxembourg EUROPEAN COMMISSION Brussels, 16.06.2011 C(2011)4423 In the published version of this decision, some information has been omitted pursuant to Article PUBLIC VERSION 17(2) of Council Regulation (EC) No 139/2004 concerning non-disclosure of business secrets and other confidential information. The omissions are MERGER PROCEDURE shown thus […]. Where possible the information omitted has been replaced by ranges of figures or a ARTICLE 6(1)(b) DECISION general description. To the notifying party: Dear Sir/Madam, Subject: Case No COMP/M.6175 - Danaher/ Beckman Coulter Commission decision pursuant to Article 6(1)(b) of Council Regulation No 139/20041 1. On 6 May 2011, the European Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which the undertaking Djanet Acquisition Corp. (USA) controlled by Danaher Corporation (USA) ("Danaher") acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the undertaking Beckman Coulter, Inc. (USA) ("Beckman") by way of public bid announced on 15 February 2011. Danaher and Beckman are designated hereinafter as the "parties (to the proposed transaction)"2. 1 OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). -
2018 Annual Report
2018 Annual Report Danaher 2018 Annual Report Financial Operating Highlights (dollars in millions except per share data and number of associates) 2018 2017 Sales $ 19,893.0 $ 18,329.7 Operating Profit $ 3,403.8 $ 2,990.4 Net Earnings $ 2,650.9 $ 2,469.8 Net Earnings Per Share (diluted) $ 3.74 $ 3.50 Operating Cash Flow $ 4,022.0 $ 3,477.8 Investing Cash Flow $ (2,949.4) $ (843.4) Financing Cash Flow $ (797.4) $ (3,098.5) Capital Expenditures $ (655.7) $ (619.6) Capital Disposals $ 6.3 $ 32.6 Free Cash Flow (Operating Cash Flow less Capital Expenditures plus Capital Disposals) $ 3,372.6 $ 2,890.8 Number of Associates 71,000 67,000 Total Assets $ 47,832.5 $ 46,648.6 Total Debt * $ 9,740.3 $ 10,522.1 Stockholders’ Equity $ 28,226.7 $ 26,367.8 Total Capitalization (Total Debt plus Stockholders’ Equity) $ 37,967.0 $ 36,889.9 * Long-Term Debt ($9,688.5 for 2018 and $10,327.4 for 2017) plus Notes Payable and Current Portion of Long-Term Debt ($51.8 for 2018 and $194.7 for 2017) All financial data set forth in this annual report relates solely to continuing operations unless otherwise indicated. 2018 Annual Report Dear Shareholders, As I begin my 30th year at Danaher, it is humbling to reflect on what our team has achieved over that time and exciting to think about the opportunities that still lie ahead. Financially and strategically, 2018 was an outstanding year. With the Danaher Business System (DBS) as our driving force, we strengthened our footholds in attractive, fast-growing markets and enhanced our competitive positions.